International Symposium on Hybrid Imaging and Theranostics
Preliminary programme
|
|
|
Thursday, October 16, 2025 |
08:30-17:00 |
Registration |
1 |
Imaging in Nuclear Medicine |
|
Chairpersons: |
9:00-9:15 |
Vera Artiko, Dragana Šobić Šaranović |
Welcome |
9:15-9:30 |
Raluca Mititelu |
Nuclear medicine in diagnosis of amyloidosis/Nuklearna medicina u dijagnostici amiloidoze |
9:30-9:45 |
Veljko Crnobrnja |
Diagnosis of amyloidosis KC Vojvodine/Dijagnoza amiloidoze u KC Vojvodine |
9:45-10:00 |
Marija Šišić |
Advantages of SPECT/CT in diagnosis of cardiac amyloidosis/Prednosti SPECT/CT-a u dijagnostici kardijalne amiloidoze |
10:00-10:15 |
|
|
10:15-10:30 |
Discussion |
10:30-10:45 |
Coffee break |
10:45-11:25 |
Commercial Symposium |
10:45-11:25 |
Commercial Symposium |
|
|
2 |
Technological advances in Nuclear Medicine |
|
Chairpersons: Marcus Hacker, Markus Diemling, … |
11:30-11:45 |
Marcus Hacker |
PET/MRI and PET/CT in primary prostate cancer/PET/MRI i PET/CT u primarnom karcinomu prostate |
11:45-12:00 |
Markus Diemling |
Dosimetry in Nuclear Medicine Therapy/Dozimetrija u radionukldinoj terapiji |
12:00-12:15 |
Marko Grahovac |
AI in nuclear medicine/Veštačka inteligencija u nuklearnoj medicini |
12:15-12:30 |
Nikola Ilić |
Data as a prerequisite for machine learning and artificial intelligence/Podaci kao preduslov za mašinsko učenje i veštačku inteligenciju |
12:30-12:45 |
Marina Popović |
Personalized Management of Papillary Thyroid Cancer: A Machine Learning Approach/Personalizovani pristup terapiji karcinoma štitaste žlezde: mašinsko učenje |
12:45-13:00 |
Discussion |
13:00-14:00 |
Welcome buffet |
|
|
14:00-14:20 |
Commercial Symposium |
GE |
14:20-14.30 |
Satellite Symposium |
KVARK |
|
|
|
3 |
Theranostics in Endocrinology |
|
Chairpersons: |
14:30-14:45 |
Miloš Žarković |
The use of contrast in echosonographic diagnosis and therapy of thyroid nodules/Upotreba kontrasta u ehosonografskoj dijagnostici i terapiji tiroidnih nodusa. |
14:45-15:00 |
Jasna Mihailović |
Radionuclide threrapy of differentiated thyroid carcinoma/Radionuklidna terapija diferentovanog karcinoma štitaste žlezde |
15:00-15:15 |
Sanja Ognjanović |
NET-Therapeutic approach/ Terapijski pristup kod neuroendokrinih tumora |
15:15-15:30 |
Miloš Stević |
Radionuclide therapy of NET/Radionuklidna terapija neuroendokrinih tumora |
15:30-15:45 |
Branislava Radović |
Radionuclide diagnostics of NET/Radionuklidna dijagnostika neuroendokrinih tumora |
15:45-16:00 |
Batool Albalooshi |
Theranostics and tandem therapy using Ac-225 and Lu-177- Dotatate for treatment of NETs/ Dubai experience/Teranostika i tandem terapija Ac-225 i Lu-177- Dotatate u terapiji NET/Iskustva iz Dubaija |
16:00-16:15 |
Discussion |
|
16:20-16:30 |
Satellite Symposium Merck |
|
16:35-16:45 |
Satellite Symposium Novartis |
Theragnostic in prostate carcinoma/Teranostika u karcinomu prostate |
16:50-17:05 |
Coffee break |
4 |
Theragnostics in prostate carcinoma |
|
Chairpersons:
|
17:05-17:20 |
Miloš Veljković |
Radionuclide diagnostics of prostate carcinoma/Radionuklidna dijagnostika karcinoma prostate |
17:20-17:35 |
Siniša Stanković |
Ga-68 PSMA in diagnosis of prostate carcinoma/Ga-68 PSMA u dijagnostici karcinoma prostate |
17:35-17:50 |
Vladimir Vukomanović |
Prostate-Specific Membrane Antigen (PSMA) theranostics for Castration-Resistant Prostate Cancer (CRPC)/PSMA teranostika karcinoma prostate |
17:50-18:05 |
Sabina Dizdarević |
Alpha targeted radionuclide treatments in prostate cancer/Alfa radionuklidna terapija u karcinomu prostate |
18:05-18:20 |
Sanja Vranješ Djurić |
Production of Tb-161-radiopharmaceuticals in Vinča Institute/Proizvodnja Tb-161-radiofarmaceutika u Institutu Vinča |
18:20-18:30 |
Discussion |
|
Poster presentations |
18:30-19:30 |
Chairpersons:
|
|
Friday, October 17, 2025 |
6 |
The Achievements in Nuclear Medicine 2024: “Milovan Antić” competition |
|
Chairpersons: Marija Šišić, Slobodanka Beatović, Drina Janković |
9:30-9:45 |
Introduction |
|
9:45-10:00 |
Vladimir Vukomanović |
Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience. Front Endocrinol (Lausanne). 2024 Jan 4;14:1270421 |
10:00-10:15 |
Jasna Mihailović |
Diagnostic Performance of F-18 FDG PET/CT in the Detection of Recurrent Colorectal Cancer: Correlation with Biochemical Markers and Conventional Imaging Modalities. J Clin Med. 2024 Jun 20;13(12):3602. |
10:20-10:30 |
Ospita specijalna bolnica
Dr Aida Afgan |
PET-CT dijagnostika |
|
|
|
|
Award “Vladimir Bošnjaković” for 2024 |
10:30-11:00 |
Chairpersons: Leposava Brajković, Miloš Stević |
11:15-12:00 |
Assembly, Serbian Society of Nuclear Medicine and Serbian Medical Society
Chairpersons: Miloš Stević, Marija Šišić |
12:00-12:30 |
Light refreshment |